16 Sep 2011
In the US when the vaccine was first recommended for adolescents in 2005, the expectation was that protection would last for 10 years; however, currently available data suggest it wanes in most adolescents within 5 years. Based on that information, a single dose at the recommended age of 11 or 12 years may not offer protection through the adolescent years at which risk for meningococcal infection is highest (16 though 21 years of age). A booster dose is now recommended at age 16.
- Meningococcal Polysaccharide Vaccine Information for Consumers
- Meningococcal Polysaccharide Vaccine Information for Healthcare Professionals (includes dosage details)
- Side Effects of Meningococcal Polysaccharide Vaccine (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
... received help me to resist pneumonia?
1 answer • 22 Jul 2010
... having any fever but blood tests showed high infection . later csf samples confirmed decease i m worried abt consequences pls guide me , her ...
2 answers • 9 Feb 2012
... typhoid vaccine. My boyfriend needs to get the inactivated vaccine before he can visit me in Hong Kong, and he lives in California in the US. He ...
1 answer • 2 Jun 2013
... developed red serus weeping wounds on truck and then peripheral area of arms and legs. could this be due to the vaccine. they dry up and weeks ...
1 answer • 9 Nov 2014
... measles or mumps in childhood. I cannot remember if I received the vaccine in early adulthood. Is it dangerous to be vaccinated now, even though ...
1 answer • 30 Jan 2015